Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]

New Targets Identified For Lupus and Rheumatoid Arthritis

Researchers part of a public-private partnership have identified new targets for the treatment of autoimmune diseases, including lupus and rheumatoid arthritis. That’s according to...

Illumina Prevails Against Ariosa in UK Patent Infringement Case

Illumina said it has won a decision in a U.K. patent court which sided with the company in ruling that one of its patents...
Smiling Beagle

Are Dogs the New Early Cancer Detection Tool?

A dog’s sense of smell—more than 10,000 times more sensitive than that of our own—has been exploited by humans for centuries. Whether it is...

Invitae to Expand NIPS Services with Singular Bio Acquisition

Invitae said today it has agreed to acquire Singular Bio for $55 million, in a deal designed to bolster the buyer’s non-invasive prenatal screening...
Nanoparticles

Sensory Nanoparticles Could Enable Early Disease Detection

The discovery that blood biomolecules form distinctive corona profiles around nanoparticles could lead to early detection tests for cancer, and possibly other diseases as...
Alzheimer's disease

Gut Microbe Dampens Parkinson’s Treatment

For some time, gut microbes have been thought to metabolize and lessen the efficacy of levodopa, the primary drug treatment for Parkinson’s disease, but...

CRISPR Pioneers Partner with GSK to Launch Laboratory for Genomics Research

Gene-editing pioneers based at the University of California (UC) are partnering with GlaxoSmithKline (GSK) to establish a new laboratory that will explore how gene...
Myanmar: Rhesus Macaque

CRISPR-Cas9 Used to Create Primate Model of Autism

Researchers headed by teams at the Chinese Academy of Sciences, and Massachusetts Institute of Technology (MIT), have used CRISPR-Cas9 gene editing to engineer macaque...
General Views Attendees and speakers

Foundation Medicine CEO Cindy Perettie’s Top ASCO 2019 Takeaways

By Cindy Perettie, CEO, Foundation Medicine The way ASCO started for me this year set the scene for what was an inspiring and fascinating weekend....
NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]

Polygenic Risk Scores Predict Heart Disease Across Diverse Populations

A new study confirms that the whole-genome approach for predicting heart disease in people who have never had a heart attack works and can...
Scroll Up